Liminatus Pharma LIMN
NASDAQ LIMN
$3.75 +0.02 (+0.54%)
As of: Oct 1, 2026 · 3:54 PM EDT

Liminatus Pharma (LIMN) Prepaid Assets (2024 - 2026)

Updated

Liminatus Pharma (LIMN) recorded Prepaid Assets of $375,371 in Q2 2026, down 15.5% from $444,086 a year earlier and down 56.9% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Prepaid Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Liminatus Pharma reported Prepaid Assets of $162,919, up 4.8% from FY2024.

  • Across earlier years, Prepaid Assets came in at $155,501 in FY2024.
  • Quarterly Prepaid Assets has ranged from $155,501 in Q4 2024 to $870,872 in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $870,872 (Q1 2026), $162,919 (Q4 2025) and $478,868 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Liminatus Pharma 4.18 Mn 4.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 375,371.00
Mar 31, 2026 870,872.00
Dec 31, 2025 162,919.00
Sep 30, 2025 478,868.00
Jun 30, 2025 444,086.00
Dec 31, 2024 155,501.00
API Access

Liminatus Pharma Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=LIMN&period=max&api_key=YOUR_API_KEY